Cargando…

Limitations and Challenges in the Stability of Cysteamine Eye Drop Compounded Formulations

Accumulation of cystine crystals in the cornea of patients suffering from cystinosis is considered pathognomonic and can lead to severe ocular complications. Cysteamine eye drop compounded formulations, commonly prepared by hospital pharmacy services, are meant to diminish the build-up of corneal cy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Martín-Sabroso, Cristina, Alonso-González, Mario, Fernández-Carballido, Ana, Aparicio-Blanco, Juan, Córdoba-Díaz, Damián, Navarro-García, Federico, Córdoba-Díaz, Manuel, Torres-Suárez, Ana I.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8779799/ https://www.ncbi.nlm.nih.gov/pubmed/35056058 http://dx.doi.org/10.3390/ph15010002

Ejemplares similares

Timeline of Translational Formulation Technologies for Cancer Therapy: Successes, Failures, and Lessons Learned Therefrom
por: Pérez-López, Alexandre, et al.
Publicado: (2020)

Physical Stability Studies of Semi-Solid Formulations from Natural Compounds Loaded with Chitosan Microspheres
por: Acosta, Niuris, et al.
Publicado: (2015)

Cysteamine Eye Drops in Hyaluronic Acid Packaged in Innovative Single-Dose Systems: Stability and Ocular Biopermanence
por: Castro-Balado, Ana, et al.
Publicado: (2022)

Ophthalmic Outcome in a Belgian Cohort of Cystinosis Patients Treated with a Compounded Preparation of Cysteamine Eye Drops: Retrospective Analysis
por: Peeters, Freya, et al.
Publicado: (2019)

Cysteamine Eye Drops in Hyaluronic Acid Packaged in Innovative Single-Dose Systems, Part II: Long-Term Stability and Clinical Ocular Biopermanence
por: Castro-Balado, Ana, et al.
Publicado: (2023)

Active Targeted Nanoformulations via Folate Receptors: State of the Art and Future Perspectives
por: Martín-Sabroso, Cristina, et al.
Publicado: (2021)

Development of a Solid Formulation Containing a Microemulsion of a Novel Artemisia Extract with Nematocidal Activity for Oral Administration
por: Perez-Roman, Ines, et al.
Publicado: (2020)

Aqueous Prostaglandin Eye Drop Formulations
por: Jansook, Phatsawee, et al.
Publicado: (2022)

Cysteamine hydrochloride eye drop solution for the treatment of corneal cystine crystal deposits in patients with cystinosis: an evidence-based review
por: Makuloluwa, Achini K, et al.
Publicado: (2018)

The Ocular Status of Cystinosis Patients Receiving a Hospital Pharmacy-Made Preparation of Cysteamine Eye Drops: A Case Series
por: Biswas, Susmito, et al.
Publicado: (2018)

An Ilomastat-CD Eye Drop Formulation to Treat Ocular Scarring
por: Mohamed-Ahmed, Abeer H. A., et al.
Publicado: (2017)

Formulation and Stability of Ataluren Eye Drop Oily Solution for Aniridia
por: Djayet, Celia, et al.
Publicado: (2020)

Anti-inflammatory and Antihistaminic Study of a Unani Eye Drop Formulation
por: Abdul, Latif, et al.
Publicado: (2010)

Monocaprin eye drop formulation to combat antibiotic resistant gonococcal blindness
por: Churchward, Colin P., et al.
Publicado: (2020)

PLGA Nanoparticles for the Intraperitoneal Administration of CBD in the Treatment of Ovarian Cancer: In Vitro and In Ovo Assessment
por: Fraguas-Sánchez, Ana I., et al.
Publicado: (2020)

Antifungal Combination Eye Drops for Fungal Keratitis Treatment
por: Díaz-Tomé, Victoria, et al.
Publicado: (2022)

Lectin Digestibility and Stability of Elderberry Antioxidants to Heat Treatment In Vitro
por: Jiménez, Pilar, et al.
Publicado: (2017)

Optimization of liposomal encapsulation for ceftazidime for developing a potential eye drop formulation
por: Wijesooriya, Chamari, et al.
Publicado: (2013)

An alternative in situ gel-formulation of levofloxacin eye drops for prolong ocular retention
por: Gupta, Himanshu, et al.
Publicado: (2015)

Transungual Delivery of Ciclopirox Is Increased 3–4-Fold by Mechanical Fenestration of Human Nail Plate in an In Vitro Model
por: Cordoba Díaz, Damian, et al.
Publicado: (2019)

Cysteamine Inhibits Glycine Utilisation and Disrupts Virulence in Pseudomonas aeruginosa
por: Fraser-Pitt, Douglas J., et al.
Publicado: (2021)

Development of prednisolone-containing eye drop formulations by cyclodextrin complexation and antimicrobial, mucoadhesive biopolymer
por: Bíró, Tivadar, et al.
Publicado: (2018)

Nepafenac-Loaded Cyclodextrin/Polymer Nanoaggregates: A New Approach to Eye Drop Formulation
por: Lorenzo-Veiga, Blanca, et al.
Publicado: (2019)

Comparison of anti-inflammatory effects of eye drops formulations after uncomplicated cataract surgery
por: Cagini, Carlo, et al.
Publicado: (2020)

Achyranthis radix Extract-Loaded Eye Drop Formulation Development and Novel Evaluation Method for Dry Eye Treatment
por: Kim, Sung-Jin, et al.
Publicado: (2020)

Novel Eye Drop Delivery Systems: Advance on Formulation Design Strategies Targeting Anterior and Posterior Segments of the Eye
por: Wang, Yaru, et al.
Publicado: (2022)

Endotoxins from a Pharmacopoeial Point of View
por: Franco, Elvira, et al.
Publicado: (2018)

A novel sustained‐release cysteamine bitartrate formulation for the treatment of cystinosis: Pharmacokinetics and safety in healthy male volunteers
por: Berends, Cécile L., et al.
Publicado: (2021)

Unexpected Toxicity of Green Tea Polyphenols in Combination with the Sambucus RIL Ebulin
por: Rojo, M. Ángeles, et al.
Publicado: (2020)

Antibody-Antineoplastic Conjugates in Gynecological Malignancies: Current Status and Future Perspectives
por: Martín-Sabroso, Cristina, et al.
Publicado: (2021)

Development and Characterization of a Tacrolimus/Hydroxypropyl-β-Cyclodextrin Eye Drop
por: García-Otero, Xurxo, et al.
Publicado: (2021)

Development and Evaluation of a Water Soluble Fluorometholone Eye Drop Formulation Employing Polymeric Micelle
por: Noh, Gyubin, et al.
Publicado: (2018)

A Novel Eye Drop Formulation for Potential Treatment of Neovascular Age-Related Macular Degeneration
por: Huang, Wen-Chia, et al.
Publicado: (2021)

Anti-Human Endoglin (hCD105) Immunotoxin—Containing Recombinant Single Chain Ribosome-Inactivating Protein Musarmin 1
por: Barriuso, Begoña, et al.
Publicado: (2016)

A monoclinic polymorph of cysteamine hydrochloride
por: Ahmad, Saeed, et al.
Publicado: (2009)

Cystamine and cysteamine as inhibitors of transglutaminase activity in vivo
por: Jeitner, Thomas M., et al.
Publicado: (2018)

A Review on the Antimutagenic and Anticancer Effects of Cysteamine
por: Lee, Chun-Man
Publicado: (2023)

Enteric-Coated Cysteamine Bitartrate in Cystinosis Patients
por: Klank, Sabrina, et al.
Publicado: (2023)

Controlled Release of Highly Hydrophilic Drugs from Novel Poly(Magnesium Acrylate) Matrix Tablets
por: Simancas-Herbada, Rebeca, et al.
Publicado: (2020)

Elderberries: A Source of Ribosome-Inactivating Proteins with Lectin Activity
por: Tejero, Jesús, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ut5kcb0c7v4mui5pao6gqvh69j